Lomitapide
ATC C10AX12 · 4 markets · 14 records
US 7 records · 5 strengths
GB 3 records · 3 strengths
- 20 mgcapsuleLojuxta 5mg capsules
- 10 mgcapsuleLojuxta 5mg capsules
- 5 mgcapsuleLojuxta 5mg capsules
CA 3 records · 3 strengths
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Lojuxta 5mg capsules
| Strength / form / release | US | GB | CA | EU |
|---|---|---|---|---|
| 20 mg capsule | Juxtapid | Lojuxta 5mg capsules | Juxtapid | |
| 10 mg capsule | Juxtapid | Lojuxta 5mg capsules | Juxtapid | |
| 5 mg capsule | Juxtapid | Lojuxta 5mg capsules | Juxtapid | |
| 30 mg capsule | Juxtapid | |||
| 2 mg capsule | Juxtapid | |||
unknown | Lojuxta 5mg capsules |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.